Skip to content

Clinical trials

Phase 1 Pulmonary Fibrosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 1 Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20212
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital3
Guangdong Hengrui Pharmaceutical Co., Ltd2
Guangzhou JOYO Pharma Co., Ltd2
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis8
Idiopathic Pulmonary Fibrosis3
Lung Diseases2
Respiratory Tract Diseases2
Idiopathic Interstitial Pneumonias1
Lung Injury1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.